Vanguard Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.09B Sell
9,446,041
-28,088
-0.3% -$6.13M 0.04% 314
2026
Q2
$1.85B Buy
9,474,129
+7,713
+0.1% +$1.6M 0.04% 347
2026
Q1
$2.13B Buy
+9,466,416
New +$2.36B 0.05% 295

Other funds holding RMD

Vanguard Capital Management's RMD Position: Q3 2026 in Review

Vanguard Capital Management reduced its ResMed (RMD) stake by 0.3% in Q3 2026, selling an estimated $6.13M and leaving 9,446,041 shares worth $2.09B. The position accounts for 0.04% of the portfolio, ranked #314.

Vanguard Capital Management first reported a position in RMD in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.13B in Q1 2026. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Vanguard Capital Management held 9,446,041 shares of ResMed worth $2.09B as of Q3 2026.
  • Vanguard Capital Management sold 28,088 ResMed shares in Q3 2026, an estimated $6.13M.
  • ResMed made up 0.04% of Vanguard Capital Management's portfolio in Q3 2026, its #314 holding.
  • Vanguard Capital Management first reported a position in ResMed in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's ResMed position peaked at $2.13B in Q1 2026.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.